Top

BMC Surgery

Published in:

Open Access 01-12-2024 | Pleural Effusion | Research

Construction and validation of a predictive model of invasive adenocarcinoma in pure ground-glass nodules less than 2 cm in diameter

Authors: Mengchao Xue, Rongyang Li, Kun Wang, Wen Liu, Junjie Liu, Zhenyi Li, Guanqing Chen, Huiying Zhang, Hui Tian

Published in: BMC Surgery | Issue 1/2024

Abstract

Objectives

In this study, we aimed to develop a multiparameter prediction model to improve the diagnostic accuracy of invasive adenocarcinoma in pulmonary pure glass nodules.

Method

We included patients with pulmonary pure glass nodules who underwent lung resection and had a clear pathology between January 2020 and January 2022 at the Qilu Hospital of Shandong University. We collected data on the clinical characteristics of the patients as well as their preoperative biomarker results and computed tomography features. Thereafter, we performed univariate and multivariate logistic regression analyses to identify independent risk factors, which were then used to develop a prediction model and nomogram. We then evaluated the recognition ability of the model via receiver operating characteristic (ROC) curve analysis and assessed its calibration ability using the Hosmer-Lemeshow test and calibration curves. Further, to assess the clinical utility of the nomogram, we performed decision curve analysis.

Result

We included 563 patients, comprising 174 and 389 cases of invasive and non-invasive adenocarcinoma, respectively, and identified seven independent risk factors, namely, maximum tumor diameter, age, serum amyloid level, pleural effusion sign, bronchial sign, tumor location, and lobulation. The area under the ROC curve was 0.839 (95% CI: 0.798–0.879) for the training cohort and 0.782 (95% CI: 0.706–0.858) for the validation cohort, indicating a relatively high predictive accuracy for the nomogram. Calibration curves for the prediction model also showed good calibration for both cohorts, and decision curve analysis showed that the clinical prediction model has clinical utility.

Conclusion

The novel nomogram thus constructed for identifying invasive adenocarcinoma in patients with isolated pulmonary pure glass nodules exhibited excellent discriminatory power, calibration capacity, and clinical utility.

Available only for authorised users

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed

Wu FZ, Huang YL, Wu CC, Tang EK, Chen CS, Mar GY, et al. Assessment of Selection Criteria for low-dose lung screening CT among Asian ethnic groups in Taiwan: from Mass Screening to specific risk-based screening for Non-smoker Lung Cancer. Clin Lung Cancer. 2016;17(5):e45–e56.PubMedCrossRef

Lin KF, Wu HF, Huang WC, Tang PL, Wu MT, Wu FZ. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer. BMC Pulm Med. 2017;17(1):120.PubMedPubMedCentralCrossRef

Wu FZ, Huang YL, Wu YJ, Tang EK, Wu MT, Chen CS, et al. Prognostic effect of implementation of the mass low-dose computed tomography lung cancer screening program: a hospital-based cohort study. Eur J Cancer Prev. 2020;29(5):445–51.PubMedCrossRef

Austin JH, Müller NL, Friedman PJ, Hansell DM, Naidich DP, Remy-Jardin M, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200(2):327–31.PubMedCrossRef

Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007;245(1):267–75.PubMedCrossRef

Takahashi S, Tanaka N, Okimoto T, Tanaka T, Ueda K, Matsumoto T, et al. Long term follow-up for small pure ground-glass nodules: implications of determining an optimum follow-up period and high-resolution CT findings to predict the growth of nodules. Jpn J Radiol. 2012;30(3):206–17.PubMedCrossRef

Lee HW, Jin KN, Lee JK, Kim DK, Chung HS, Heo EY, et al. Long-term Follow-Up of Ground-Glass nodules after 5 years of Stability. J Thorac Oncol. 2019;14(8):1370–7.PubMedCrossRef

Cho J, Kim ES, Kim SJ, Lee YJ, Park JS, Cho YJ, et al. Long-term follow-up of small Pulmonary Ground-Glass nodules stable for 3 years: implications of the proper follow-up period and risk factors for subsequent growth. J Thorac Oncol. 2016;11(9):1453–9.PubMedCrossRef

10.

Tang EK, Chen CS, Wu CC, Wu MT, Yang TL, Liang HL, et al. Natural history of Persistent Pulmonary Subsolid nodules: Long-Term Observation of different interval growth. Heart Lung Circ. 2019;28(11):1747–54.PubMedCrossRef

11.

Sugi K, Kobayashi S, Sudou M, Sakano H, Matsuda E, Okabe K. Long-term prognosis of video-assisted limited surgery for early lung cancer. Eur J Cardiothorac Surg. 2010;37(2):456–60.PubMed

12.

Koike T, Togashi K, Shirato T, Sato S, Hirahara H, Sugawara M, et al. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg. 2009;88(4):1106–11.PubMedCrossRef

13.

Ito M, Miyata Y, Kushitani K, Yoshiya T, Mimae T, Ibuki Y, et al. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications. Lung Cancer. 2014;85(2):270–5.PubMedCrossRef

14.

Boland JM, Froemming AT, Wampfler JA, Maldonado F, Peikert T, Hyland C, et al. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma–analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules. Hum Pathol. 2016;51:41–50.PubMedCrossRef

15.

Van Schil PE, Asamura H, Rusch VW, Mitsudomi T, Tsuboi M, Brambilla E, et al. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J. 2012;39(2):478–86.PubMedCrossRef

16.

Shah R, Sabanathan S, Richardson J, Mearns AJ, Goulden C. Results of surgical treatment of stage I and II lung cancer. J Cardiovasc Surg (Torino). 1996;37(2):169–72.PubMed

17.

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51.PubMedCrossRef

18.

Chu ZG, Li WJ, Fu BJ, Lv FJ. CT characteristics for Predicting Invasiveness in pulmonary pure ground-glass nodules. AJR Am J Roentgenol. 2020;215(2):351–8.PubMedCrossRef

19.

Xiang W, Xing Y, Jiang S, Chen G, Mao H, Labh K, et al. Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤ 10 mm on thin-section computed tomography. Cancer Imaging. 2014;14(1):33.PubMedPubMedCentralCrossRef

20.

Lee SM, Park CM, Goo JM, Lee HJ, Wi JY, Kang CH. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology. 2013;268(1):265–73.PubMedCrossRef

21.

Wu F, Tian SP, Jin X, Jing R, Yang YQ, Jin M, et al. CT and histopathologic characteristics of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter. Eur Radiol. 2017;27(10):4037–43.PubMedCrossRef

22.

Lee GD, Park CH, Park HS, Byun MK, Lee IJ, Kim TH, et al. Lung adenocarcinoma invasiveness risk in pure ground-glass opacity lung nodules smaller than 2 cm. Thorac Cardiovasc Surg. 2019;67(4):321–8.PubMedCrossRef

23.

Lim HJ, Ahn S, Lee KS, Han J, Shim YM, Woo S, et al. Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest. 2013;144(4):1291–9.PubMedCrossRef

24.

Liang J, Xu XQ, Xu H, Yuan M, Zhang W, Shi ZF, et al. Using the CT features to differentiate invasive pulmonary adenocarcinoma from pre-invasive lesion appearing as pure or mixed ground-glass nodules. Br J Radiol. 2015;88(1053):20140811.PubMedPubMedCentralCrossRef

25.

Jin X, Zhao SH, Gao J, Wang DJ, Wu J, Wu CC, et al. CT characteristics and pathological implications of early stage (T1N0M0) lung adenocarcinoma with pure ground-glass opacity. Eur Radiol. 2015;25(9):2532–40.PubMedCrossRef

26.

Han L, Zhang P, Wang Y, Gao Z, Wang H, Li X, et al. CT quantitative parameters to predict the invasiveness of lung pure ground-glass nodules (pGGNs). Clin Radiol. 2018;73(5):504.e1-.e7CrossRef

27.

Gao F, Sun Y, Zhang G, Zheng X, Li M, Hua Y. CT characterization of different pathological types of subcentimeter pulmonary ground-glass nodular lesions. Br J Radiol. 2019;92(1094):20180204.PubMedCrossRef

28.

Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology. 2001;220(3):803–9.PubMedCrossRef

29.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.PubMedPubMedCentralCrossRef

30.

Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63(7):07tr1.CrossRef

31.

Nattino G, Pennell ML, Lemeshow S. Assessing the goodness of fit of logistic regression models in large samples: a modification of the Hosmer-Lemeshow test. Biometrics. 2020;76(2):549–60.MathSciNetPubMedCrossRef

32.

Rosenfeld JP, Donchin E. Resampling (bootstrapping) the mean: a definite do. Psychophysiology. 2015;52(7):969–72.PubMedCrossRef

33.

Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21(10):1643–8.PubMedPubMedCentralCrossRef

34.

Andrade JR, Rocha RD, Falsarella PM, Rahal Junior A, Santos RSD, Franceschini JP, et al. CT-guided percutaneous core needle biopsy of pulmonary nodules smaller than 2 cm: technical aspects and factors influencing accuracy. J Bras Pneumol. 2018;44(4):307–14.PubMedPubMedCentralCrossRef

35.

Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C, et al. CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol. 2003;180(6):1665–9.PubMedCrossRef

36.

Jones KD. Whence lepidic? The history of a Canadian neologism. Arch Pathol Lab Med. 2013;137(12):1822–4.PubMedCrossRef

37.

Lee JH, Park CM, Lee SM, Kim H, McAdams HP, Goo JM. Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: their natural course and predictors of interval growth. Eur Radiol. 2016;26(6):1529–37.PubMedCrossRef

38.

Lee SW, Leem CS, Kim TJ, Lee KW, Chung JH, Jheon S, et al. The long-term course of ground-glass opacities detected on thin-section computed tomography. Respir Med. 2013;107(6):904–10.PubMedCrossRef

39.

Hu F, Huang H, Jiang Y, Feng M, Wang H, Tang M, et al. Discriminating invasive adenocarcinoma among lung pure ground-glass nodules: a multi-parameter prediction model. J Thorac Dis. 2021;13(9):5383–94.PubMedPubMedCentralCrossRef

40.

Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with bayesian analysis. Part I. Theory. Radiology. 1993;186(2):405–13.PubMedCrossRef

41.

Winer-Muram HT. The solitary pulmonary nodule. Radiology. 2006;239(1):34–49.PubMedCrossRef

42.

Lee HJ, Goo JM, Lee CH, Park CM, Kim KG, Park EA, et al. Predictive CT findings of malignancy in ground-glass nodules on thin-section chest CT: the effects on radiologist performance. Eur Radiol. 2009;19(3):552–60.PubMedCrossRef

43.

Liu LH, Liu M, Wei R, Jin EH, Liu YH, Xu L, et al. CT findings of persistent pure ground glass opacity: can we predict the invasiveness? Asian Pac J Cancer Prev. 2015;16(5):1925–8.PubMedCrossRef

44.

Nambu A, Araki T, Taguchi Y, Ozawa K, Miyata K, Miyazawa M, et al. Focal area of ground-glass opacity and ground-glass opacity predominance on thin-section CT: discrimination between neoplastic and non-neoplastic lesions. Clin Radiol. 2005;60(9):1006–17.PubMedCrossRef

45.

Yanagawa M, Johkoh T, Noguchi M, Morii E, Shintani Y, Okumura M, et al. Radiological prediction of tumor invasiveness of lung adenocarcinoma on thin-section CT. Med (Baltim). 2017;96(11):e6331.CrossRef

46.

Takashima S, Maruyama Y, Hasegawa M, Yamanda T, Honda T, Kadoya M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol. 2003;180(3):817–26.PubMedCrossRef

47.

Mei X, Wang R, Yang W, Qian F, Ye X, Zhu L, et al. Predicting malignancy of pulmonary ground-glass nodules and their invasiveness by random forest. J Thorac Dis. 2018;10(1):458–63.PubMedPubMedCentralCrossRef

48.

Weng Q, Zhou L, Wang H, Hui J, Chen M, Pang P, et al. A radiomics model for determining the invasiveness of solitary pulmonary nodules that manifest as part-solid nodules. Clin Radiol. 2019;74(12):933–43.PubMedCrossRef

49.

Xing Y, Li Z, Jiang S, Xiang W, Sun X. Analysis of pre-invasive lung adenocarcinoma lesions on thin-section computerized tomography. Clin Respir J. 2015;9(3):289–96.PubMedCrossRef

50.

Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997;157(8):849–55.PubMedCrossRef

51.

McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369(10):910–9.PubMedPubMedCentralCrossRef

52.

Chung K, Ciompi F, Scholten ET, Goo JM, Prokop M, Jacobs C, et al. Visual discrimination of screen-detected persistent from transient subsolid nodules: an observer study. PLoS ONE. 2018;13(2):e0191874.PubMedPubMedCentralCrossRef

53.

Furuya K, Murayama S, Soeda H, Murakami J, Ichinose Y, Yabuuchi H, et al. New classification of small pulmonary nodules by margin characteristics on high-resolution CT. Acta Radiol. 1999;40(5):496–504.PubMedCrossRef

54.

Hu H, Wang Q, Tang H, Xiong L, Lin Q. Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: differences between malignant and benign. Thorac Cancer. 2016;7(1):80–7.PubMedCrossRef

55.

Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer. 1974;33(4):916–22.PubMedCrossRef

56.

Memon A, Zawadzki ZA. Malignant effusions: diagnostic evaluation and therapeutic strategy. Curr Probl Cancer. 1981;5(8):1–30.PubMedCrossRef

57.

Yanagawa M, Tsubamoto M, Satoh Y, Hata A, Miyata T, Yoshida Y, et al. Lung adenocarcinoma at CT with 0.25-mm section thickness and a 2048 Matrix: high-spatial-resolution imaging for Predicting Invasiveness. Radiology. 2020;297(2):462–71.PubMedCrossRef

58.

Seyama K, Nukiwa T, Takahashi K, Takahashi H, Kira S. Amylase mRNA transcripts in normal tissues and neoplasms: the implication of different expressions of amylase isogenes. J Cancer Res Clin Oncol. 1994;120(4):213–20.PubMedCrossRef

59.

Tomita N, Matsuura N, Horii A, Emi M, Nishide T, Ogawa M, et al. Expression of alpha-amylase in human lung cancers. Cancer Res. 1988;48(11):3292–6.PubMed

60.

Casadei Gardini A, Mariotti M, Lucchesi A, Pini S, Valgiusti M, Bravaccini S, et al. Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report. BMC Cancer. 2016;16:118.PubMedPubMedCentralCrossRef

61.

Katayama S, Ikeuchi M, Kanazawa Y, Akanuma Y, Kosaka K, Takeuchi T, et al. Amylase-producing lung cancer: case report and review of the literature. Cancer. 1981;48(11):2499–502.PubMedCrossRef

62.

Morohoshi T, Nakamura N, Hayashi K, Kanda M. Amylase producing lung cancer. Electronmicroscopical and biochemical studies. Virchows Arch Pathol Anat Histol. 1980;387(2):125–32.CrossRef

63.

Tsukawaki M, Izawa M, Yoshida M, Araki N, Hashiba Y, Nakagawa H, et al. A case of amylase-producing lung cancer. Intern Med. 1992;31(1):60–3.PubMedCrossRef

64.

Lenler-Petersen P, Vejby-Christensen H, Brock A, Hvidman LE, Axelgaard G. [Amylase-producing lung tumors]. Ugeskr Laeger. 1989;151(2):83–5.PubMed

65.

Yamazaki S, Ebisawa S, Yasuo M, Urushihata K, Koizumi T, Fujimoto K, et al. Small-cell lung carcinoma produces salivary-type amylase: a case report with review. Intern Med. 2007;46(12):883–7.PubMedCrossRef

66.

Minami S, Komuta K, Asai M. [A case of amylase-producing lung cancer]. Nihon Kokyuki Gakkai Zasshi. 2003;41(10):717–21.PubMed

67.

Kamio T, Sameshima K, Irie J, Shigematsu K, Kawai K, Tsuchiyama H, et al. [Two cases of amylase-producing lung cancer]. Gan No Rinsho. 1989;35(6):735–40.PubMed

68.

Kitazawa M, Nakagawa M, Baba O, Sumiyoshi K, Saito Y, Nishimura T, et al. [A case of amylase producing lung cancer]. Kokyu Junkan. 1993;41(4):393–6.

69.

Nakao M, Kodama T, Sasaki M, Kuroda K. [A case of ectopic amylase-producing lung cancer]. Kyobu Geka. 1996;49(13):1069–73.PubMed

70.

Nakata Y, Kubota A, Mori Y, Matsumoto A. [An autopsied case of an amylase-producing lung cancer]. Gan No Rinsho. 1988;34(7):881–5.PubMed

71.

Hayashi Y, Fukayama M, Koike M, Nakayama T. Amylase in human lungs and the female genital tract. Histochemical and immunohistochemical localization. Histochemistry. 1986;85(6):491–6.PubMedCrossRef

72.

Lenler-Petersen P, Grove A, Brock A, Jelnes R. Alpha-amylase in resectable lung cancer. Eur Respir J. 1994;7(5):941–5.PubMedCrossRef

73.

Martin PC, Sarma DP. Amylase-producing lung cancer. J Surg Oncol. 1982;21(1):30–2.PubMedCrossRef

Title: Construction and validation of a predictive model of invasive adenocarcinoma in pure ground-glass nodules less than 2 cm in diameter
Authors: Mengchao Xue
Rongyang Li
Kun Wang
Wen Liu
Junjie Liu
Zhenyi Li
Guanqing Chen
Huiying Zhang
Hui Tian
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: Pleural Effusion
Published in: BMC Surgery / Issue 1/2024
Electronic ISSN: 1471-2482
DOI: https://doi.org/10.1186/s12893-024-02341-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Construction and validation of a predictive model of invasive adenocarcinoma in pure ground-glass nodules less than 2 cm in diameter

Abstract

Objectives

Method

Result

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Method

Result

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Distinct risk factors of lateral lymph node metastasis in patients with papillary thyroid cancer based on age stratification

Short-term and long-term outcomes after robotic radical surgery for rectal gastrointestinal stromal tumor

Surgical treatment outcomes of acetabular posterior wall and posterior column fractures using 3D printing technology and individualized custom-made metal plates: a retrospective study

One and five-year efficacy of tension-free vaginal tape (TVT) abbrevo and TVT-obturator in the treatment of stress urinary incontinence: a retrospective study

Anastomosis selection in liver transplantation for recipients with unusable recipient hepatic arteries: a bayesian network meta-analysis

Treatment for benign skin lesion in zygomatic-infraorbital region by the expanded multi-lobe cervicofacial advancement rotation flap in pediatric patients